CARDIO DIAGNOSTICS HOLDINGS (CDIO) Stock Analyst Earnings Estimates
NASDAQ:CDIO - Nasdaq - US14159C2026 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.1K | 34.9K 104.09% | 535.5K 1,434.38% | 25.5M 4,661.90% | ||
| EBITDA YoY % growth | -4.53M -655.00% | -7.131M -57.42% | -8.089M -13.44% | N/A | N/A | |
| EBIT YoY % growth | -4.55M -633.87% | -7.243M -59.18% | -8.366M -15.51% | -5.627M 32.73% | -11.475M -103.92% | |
| Operating Margin | N/A | -42,353.80% | -23,971.06% | -1,050.86% | -45.00% | |
| EPS YoY % growth | N/A | -19.80 25.63% | -9.90 50.00% | -7.65 22.73% | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -1.84 -2.00% | -0.06 96.60% | -0.06 79.60% |
| Revenue Q2Q % growth | 76.5K 872.05% | 153K 2,225.23% | 255K 5,000.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.406M -9.60% | -1.427M -1.28% | -1.384M 8.72% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.97 83.83% | -1.84 | 0.87 | 47.17% |
| Q4 2024 Q2Q % growth | -0.30 | -1.84 | 1.54 | 83.66% |
| Q3 2024 Q2Q % growth | -1.80 62.50% | -3.06 | 1.26 | 41.18% |
| Q2 2024 Q2Q % growth | -1.80 84.62% | -3.37 | 1.57 | 46.52% |
| Q1 2024 Q2Q % growth | -6.00 -81.82% | -2.75 | -3.25 | -117.86% |
| Q4 2023 Q2Q % growth | 0.00 100.00% | -4.13 | 4.13 | 100.00% |
| Q3 2023 Q2Q % growth | -4.80 -900.00% | -8.42 | 3.62 | 42.96% |
| Q2 2023 Q2Q % growth | -11.70 | -5.66 | -6.04 | -106.68% |
| Q1 2023 Q2Q % growth | -3.30 | -5.51 | 2.21 | 40.09% |
| Q4 2022 Q2Q % growth | -2.70 | -2.75 | 0.05 | 1.96% |
| Q3 2022 Q2Q % growth | 0.60 | -20.20 | 20.80 | 102.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 940K 5,800.82% | 51K | 889K | 1,743.14% |
| Q4 2024 Q2Q % growth | 5K -5.84% | 25.5K | -20.5K | -80.39% |
| Q3 2024 Q2Q % growth | 6.58K -34.40% | 107.1K | -100.52K | -93.86% |
| Q2 2024 Q2Q % growth | 7.87K 293.50% | 114.75K | -106.88K | -93.14% |
| Q1 2024 Q2Q % growth | 15.93K | 51K | -35.07K | -68.76% |
| Q4 2023 Q2Q % growth | 5.31K 458.95% | 255K | -249.69K | -97.92% |
| Q3 2023 Q2Q % growth | 10.03K | 127.5K | -117.47K | -92.13% |
| Q2 2023 Q2Q % growth | 2K | 61.2K | -59.2K | -96.73% |
| Q1 2023 Q2Q % growth | 30.6K | -30.6K | -100.00% | |
| Q4 2022 Q2Q % growth | 950 | 408K | -407.05K | -99.77% |
| Q3 2022 Q2Q % growth | 102K | -102K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2900% | 0% | -2900% |
| Revenue | 0% | 0% | 0% | 0% |